PepGen, Inc
321 Harrison Ave Ste 800
Boston, MA 02118
PepGen, Inc., based in Boston, MA, is dedicated to developing a new generation of disease-modifying therapies through its proprietary Enhanced Delivery Oligonucleotide (EDO) platform. The company aims to create therapeutics that safely and effectively target the root causes of serious genetic neuromuscular and neurological diseases.
With a focus on advancing transformative therapies, PepGen is committed to pioneering science in the field of genetic therapies. Their clinical development pipeline includes promising programs, underscoring their dedication to addressing unmet medical needs.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.